Summary of Bill S 2000

Bill Number: S 2000

Title: Relates to mandatory health insurance coverage for follow-up screening or diagnostic services for lung cancer

Status: Substituted by A1195A

Introduced: January 14, 2025

Classification: Bill

Purpose and Intent

Bill S 2000 aims to ensure that individuals diagnosed with lung cancer have access to necessary follow-up screening and diagnostic services through mandatory health insurance coverage. The intent is to improve early detection and treatment outcomes for lung cancer patients, thereby enhancing their chances of survival and quality of life.

Key Provisions

• Mandatory Coverage: The bill mandates that health insurance plans provide coverage for follow-up screening and diagnostic services specifically for lung cancer.
• Scope of Services: The services covered would include, but may not be limited to, imaging tests (such as CT scans), biopsies, and other diagnostic procedures deemed necessary by healthcare providers.
• Patient Access: The bill is designed to eliminate financial barriers for patients, ensuring that they can access these critical services without incurring prohibitive out-of-pocket costs.

Affected Parties

• Patients: Individuals diagnosed with lung cancer will benefit directly from the mandated coverage, allowing for timely follow-up care.
• Healthcare Providers: Medical professionals involved in the diagnosis and treatment of lung cancer will have the assurance that necessary follow-up services are covered, potentially leading to better patient outcomes.
• Insurance Companies: Health insurers will be required to adjust their policies to comply with the new coverage mandates, which may impact their operational costs and pricing structures.

Legislative Timeline

• January 14, 2025: Bill S 2000 was introduced and referred to the Insurance Committee.
• February 3, 2025: The bill was reported for the first time.
• February 4, 2025: The bill advanced to the second reading.
• February 5, 2025: The bill advanced to the third reading.
• March 18, 2025: The bill passed in the Senate and was delivered to the Assembly.
• May 19, 2025: The bill was recalled from the Assembly and returned to the Senate, where it was restored to third reading and amended.
• May 29, 2025: The bill was substituted by A1195A.

Related Bills

• S 8553: A prior-session bill related to lung cancer screening and diagnostic services.
• A 1195: A companion bill that aligns with the objectives of S 2000.

Conclusion

Bill S 2000 represents a significant step towards improving healthcare access for lung cancer patients by mandating insurance coverage for essential follow-up services. The legislative process has seen various actions, culminating in its substitution by A1195A, indicating ongoing discussions and adjustments to the proposed legislation.